Feedback
Settings

Settings

Goto Application

1,594,666 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

(NPCC:US AND CTR:WO)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 159,467
1.WO/1999/035170COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
WO - 15.07.1999
Int.Class C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
 Appl.No PCT/US1999/000106 Applicant GENENTECH, INC. Inventor BOTSTEIN, David
The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act of predictors of the prognosis of tumor treatment.
2.WO/2005/041859CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY.
WO - 12.05.2005
Int.Class C12N 15/87
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
 Appl.No PCT/US2004/013456 Applicant SIRNA THERAPEUTICS, INC. Inventor VARGEESE, Chandra
This invention features conjugates, degradable linkers, compositions, methods of synthesis, and applications thereof, including cholesterol, galactosamine, and N-acetyl galactosamine derived conjugates of biologically active compounds, including antibodies, antivirals, chemotherapeutics, peptides, proteins, hormones, nucleosides, nucleotides, non-nucleosides, and nucleic acids including enzymatic nucleic acids, DNAzymes, allozymes, antisense, dsRNA, siNA, siRNA, triplex oligonucleotides, 2,5-A chimeras, decoys and aptamers.
3.WO/2000/067811BIOSTABLE POLYETHER POLYURETHANE PRODUCT
WO - 16.11.2000
Int.Class A61L 29/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
29Materials for catheters or for coating catheters
04Macromolecular materials
06obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
 Appl.No PCT/IE1999/000037 Applicant SALVIAC LIMITED Inventor BRADY, Eamon
A biostable polyether polyurethane article comprises a medical implant and/or a substratum for tissue and/or cell growth formed from an organic diisocyanate, a polyether polyol, a chain extender and a blowing agent. The density of the biostable polyether polyurethane article is less than 200 kg/m3. The ratios of the reaction components are selected to promote the formation of a three dimensional porous molecular structure of polyether polyurethane biomaterial.
4.WO/2000/063191NOVEL POLYMORPHIC FORMS OF AN ANTIDIABETIC AGENT: PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM
WO - 26.10.2000
Int.Class A61K 31/538
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
538ortho- or peri-condensed with carbocyclic ring systems
 Appl.No PCT/IB1999/000681 Applicant DR. REDDY'S RESEARCH FOUNDATION Inventor GADDAM, Om, Reddy
This invention relates to novel polymorphic/pseudopolymorphic forms of arginine salt of 3-[4-[2-(phenoxazin-10-y1)ethoxy]pheny1]-2-ethoxypropanoic acid, having formula (I). The invention also relates to a pharmaceutical composition comprising the novel polymorphic form or their mixture and a pharmaceutically acceptable carrier. The polymorphic forms of the present invention are more active, as antidiabetic and hypolipidemic agent, than the novel 3-[4-[2-(phenoxazin-10-y1)ethoxy]phenyl]-2-ethoxypropanoic acid.
5.WO/2001/022228SYSTEM AND METHOD FOR PRODUCING A VERIFICATION SYSTEM FOR VERIFYING PROCEDURE INTERFACES
WO - 29.03.2001
Int.Class G06F 11/36
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
FELECTRIC DIGITAL DATA PROCESSING
11Error detection; Error correction; Monitoring
36Preventing errors by testing or debugging of software
 Appl.No PCT/RU1999/000340 Applicant NORTEL NETWORKS LIMITED Inventor BURDONOV, Igor
A verification system for a procedure interface is generated by using formal specifications of the procedure interface and generating test suites from the formal specifications. The formal specifications are independent from implementation of the procedure interface. Accordingly, the test suites are also implementation independent. Thus, a verification system comprising the test suites may be efficiently produced for verifying the procedure interface of different implementations.
6.WO/2006/006948METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
WO - 19.01.2006
Int.Class G06F 19/00
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
FELECTRIC DIGITAL DATA PROCESSING
19Digital computing or data processing equipment or methods, specially adapted for specific applications
 Appl.No PCT/US2004/014885 Applicant DHARMACON, INC. Inventor LEAKE, Devin
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.
7.WO/2002/008370CLEANING COMPOSITION
WO - 31.01.2002
Int.Class C11D 3/12
CCHEMISTRY; METALLURGY
11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
3Other compounding ingredients of detergent compositions covered in group C11D1/101
02Inorganic compounds
12Water-insoluble compounds
 Appl.No PCT/US2000/019619 Applicant THE PROCTER & GAMBLE COMPANY Inventor
A method of removing cooked-, baked-, or burnt-on food soil from cookware and tableware comprising washing the cookware/tableware in an automatic dishwashing machine in the presence of an organic solvent system having a wash liquor concentration of from about 100 to about 5000 ppmm. The method includes the storage and delivery of organic solvent compositions and dishwashing detergent composition from multi-compartment containers. The method provides excellent removal of stubborn soils which are very difficult to remove in a conventional automatic dishwashing process. Automatic detergent dishwashing compositions and hard-surface detergent compositions comprising organic solvent systems for the removal of cooked-, baked-, or burnt-on food soil from cookware and tableware are also disclosed.
8.WO/2002/008284COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISORDERS INVOLVING ANGIOGENESIS
WO - 31.01.2002
Int.Class A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
 Appl.No PCT/US2001/021735 Applicant GENENTECH, INC. Inventor BAKER, Kevin, P.
Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
9.WO/2008/066525SYSTEM AND METHOD FOR PRODUCING DYNAMIC CONDITIONS INCLUDING IN VIVO HEMODYNAMIC CONDITIONS IN A THREE DIMENSIONAL TUBULAR STRUCTURE
WO - 05.06.2008
Int.Class A01N 1/02
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
1Preservation of bodies of humans or animals, or parts thereof
02Preservation of living parts
 Appl.No PCT/US2006/045715 Applicant DANCU, Michael, B. Inventor DANCU, Michael, B.
A system and method is provided for producing dynamic conditions, including in vivo dynamic conditions, in a specimen or any three-dimensional tubular structure, which passes fluid from one location to another. The system can produce predetermined dynamic conditions in specified regions of the tubular structure or specimen, including second order dynamic conditions resulting from dynamic conditions produced by the system in conjunction with perturbations of the tubular structure.
10.WO/2005/065035DISTRIBUTED AND CENTRALIZED MEDIA ACCESS CONTROL DEVICE AND METHOD
WO - 21.07.2005
Int.Class H04L 12/28
HELECTRICITY
04ELECTRIC COMMUNICATION TECHNIQUE
LTRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
12Data switching networks
28characterised by path configuration, e.g. LAN or WAN
 Appl.No PCT/IL2005/000021 Applicant KUPERSHMIDT, Yefim Inventor KUPERSHMIDT, Yefim
Distributed media access control devices (A-G) and methods centralized media access control devices and methods. Networks (10, 20) that utilize distributed media access control schemes. Networks (10, 20) that utilize centralized access control schemes. Ultra-wide band devices and methods.
# -